EIF3I and neoplasm: The IDH1 (R132H) mutation had no significant impact on expression status of eIF3I or eIF4H positive tumor cells (Figure S3).Error bars are partly missing because of the low number of samples or similar tissue intensity scores in the immunohistochemical evaluation.